According to the "2016-2020 China Medical Robot Industry In-Depth Survey and Investment Prospects Forecast Report", the global medical device market will reach 514 billion US dollars in 2020, and the compound annual growth rate will be 5% between 2013 and 2020. Global medical device R&D investment will reach US$30.5 billion in 2020, with a compound annual growth rate of approximately 4.2% between 2013 and 2020. The final direction of medical devices in the future must be intelligent, and the continuous investment in research and development will move in this direction. Medical robots are the ultimate direction of medical device intelligence, and their proportion in the medical device market will become larger and larger. At present, the North American market is still the largest market, and the future focus will gradually shift to the Asian market. At the CCF·GAIR Global Artificial Intelligence and Robotics Summit on August 13, 2016, Prof. Wang Tianmiao delivered a keynote speech on “Thinking about Robot Development – ​​Academics to Industryâ€. In the gap before the speech, Professor Wang Tianmiao shared the topic of medical robots that everyone cares about. Academic to industry From the academic circle to the industry, which aspect do you think robots will be the first to generate a boom? Wang Tianmiao: The increase in labor costs and the increase in the cost of renting land may be the main reason why companies use robots. At present, domestic high-end robots are mainly imported, and low-end industrial auxiliary robots such as manufacturing, grinding, injection molding and handling are being more and more localized. This is the development status. I believe that in the future, there will be a rise in service robots, including robot assistants, chat robots, and accompanying robots, which will appear in banks, homes, hotels, and hospitals. I believe that these points will be confirmed in the next five years. Development bottleneck of medical robots Media: As we all know, you have made great achievements in medical robots. Would you like to ask if you have any bottlenecks in the process of medical robots from academic to industrial transformation? Wang Tianmiao: The important point that medical robots are different from other robots is that they involve life and health. They must be safe, so they must be maintained through very strict means such as qualification certification and clinical trials. However, the corresponding experimental period is long, and the slow progress of research and development also restricts the development of medical robots. The development of medical robots differs in academic and practical Given these development bottlenecks, what are the differences in research and development methods in academic research and industrial practice? Wang Tianmiao: Academically, we generally start from a complete system, establish academic planning, set targets, and conduct security control. In practice, it may not be fully rolled out at present, and must focus on one aspect, such as orthopedics, pediatrics, and so on. What are the mature medical robots in the industry? Wang Tianmiao: "At present, in the world, first of all, the Da Vinci surgical robot in the United States is doing a better job. Then Israel's Rewalk is more prominent in the wearable field, and the French Rosa robot is also widely used. From the domestic point of view, like Tianzhihang, focusing on orthopedics, it has been licensed and listed on the New Third Board. The products have been applied to domestic hospitals such as Jishuitan Hospital." Da Vinci surgical robot The Da Vinci Robot is the most advanced robotic surgical aid system currently developed by Intuitive Surgical Inc. and is an outstanding representative of a new generation of minimally invasive surgical techniques. With intelligent robotic arm assist and high-definition 3D imaging systems, it integrates many emerging disciplines to achieve minimally invasive surgery, functionalization, intelligence and digitization. It is designed to perform complex surgical procedures by using minimally invasive methods. The “surgical robot†consists of three parts. The following figures are from left to right: surgeon console, bedside robot system, imaging system. Da Vinci Surgical Robot System Sculptra,Sculptra Injections,Sculptra Filler,Sculptra Treatment Qingdao Beautiful Skin Biotechnology Co., Ltd , https://www.hafilleresthetic.com